161 – 170 of 171
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis.
(
- Contribution to journal › Article
-
Mark
Longitudinal cerebrospinal fluid biomarker measurements in preclinical sporadic Alzheimer's disease : A prospective 9-year study
(
- Contribution to journal › Article
- 2014
-
Mark
Levels of cerebrospinal fluid α-synuclein oligomers are increased in Parkinson's disease with dementia and dementia with Lewy bodies compared to Alzheimer's disease.
(
- Contribution to journal › Article
-
Mark
Accuracy of Brain Amyloid Detection in Clinical Practice Using Cerebrospinal Fluid β-Amyloid 42: A Cross-Validation Study Against Amyloid Positron Emission Tomography.
(
- Contribution to journal › Article
-
Mark
CSF neurofilament light differs in neurodegenerative diseases and predicts severity and survival.
(
- Contribution to journal › Article
-
Mark
Apolipoprotein E Genotype and the Diagnostic Accuracy of Cerebrospinal Fluid Biomarkers for Alzheimer Disease.
(
- Contribution to journal › Article
-
Mark
Monitoring of β-amyloid dynamics after human traumatic brain injury
(
- Contribution to journal › Article
- 2013
-
Mark
Cerebrospinal Fluid (CSF) 25-Hydroxyvitamin D Concentration and CSF Acetylcholinesterase Activity Are Reduced in Patients with Alzheimer's Disease
(
- Contribution to journal › Article
-
Mark
Serum but not cerebrospinal fluid levels of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 (IGFBP-3) are increased in Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Reduced cerebrospinal fluid level of thyroxine in patients with Alzheimer's disease
(
- Contribution to journal › Article